IP Library › Granted Patent US 11,952,627
Granted Patent B2
US 11,952,627 · App. 18/448,618 · Granted Apr 9, 2024

Methods for identifying a location of an RNA in a biological sample

Inventor: Marlon Stoeckius (Stockholm, SE)
Assignee: 10x Genomics, Inc.
C12Q1/6874C12Q1/485C12Q1/6806C12Q1/686C12Q1/6876C12Y207/07007C12Y301/26004C12Y605/01001G01N2333/9015G01N2333/9126G01N2333/922
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,952,627
App. No.
18/448,618
Filed
Aug 11, 2023
Granted
Apr 9, 2024
Kind
B2
Art Unit
1637
USPC
435/6.1
Abstract

Provided herein are methods of identifying a location of an RNA in a sample that include: (a) contacting the sample with an array comprising capture probes, where a capture probe comprises a capture domain and a spatial barcode; (b) releasing the RNA from the sample; (c) extending a 3′ end of the capture probe using the capture domain-bound RNA as a template; (d) generating nick(s) in the extended capture probe-hybridized RNA and performing random-primed DNA synthesis; (e) performing end repair on the second strand DNA molecule; (f) adding a single adenosine nucleotide to the 3′ end of the extended capture probe; (g) ligating a double-stranded sequencing adaptor to the double-stranded DNA product; and (h) determining all or a part of the sequence of the RNA, and the sequence of the spatial barcode, or complements thereof, and using the determined sequences to identify the location of the RNA in the sample.

Claims (39)

1. A method of identifying a location of an RNA in a biological sample, the method comprising:

(a) contacting the biological sample with an array comprising a plurality of capture probes, wherein a capture probe of the plurality of capture probes comprises a capture domain and a spatial barcode;

(b) releasing the RNA from the biological sample, wherein the RNA released from the biological sample is bound by the capture domain of the capture probe;

(c) extending a 3′ end of the capture probe using the RNA bound to the capture domain as a template, thereby generating an extended capture probe hybridized to the RNA;

(d) performing random-primed DNA synthesis, thereby replacing the RNA with a second strand DNA molecule hybridized to the extended capture probe to generate a double-stranded DNA product;

(e) ligating a double-stranded sequencing adaptor to the double-stranded DNA product and

(f) determining a nucleic acid sequence of (i) all or a part of the second strand DNA molecule or a complement thereof, and (ii) the spatial barcode or a complement thereof, and using the determined nucleic acid sequences of (i) and (ii) to identify the location of the RNA in the biological sample.

2. The method of claim 1 , further comprising, between steps (c) and (d), generating one or more nick(s) in the RNA hybridized to the extended capture probe.

3. The method of claim 1 , further comprising, after step (d), performing end repair on the second strand DNA molecule hybridized to the extended capture probe to generate a blunt-ended double-stranded DNA product.

4. The method of claim 3 , further comprising adding a single adenosine (A) nucleotide to the 3′ end of the extended capture probe in the blunt-ended double-stranded DNA product.

5. The method of claim 2 , wherein the generating of the one or more nick(s) is performed using RNAse H.

6. The method of claim 1 , wherein the random-primed DNA synthesis is performed using DNA polymerase I.

7. The method of claim 4 , wherein the end repair is performed using a Klenow fragment and/or T4 DNA polymerase; the adding a single adenosine (A) nucleotide is performed using Taq polymerase; and the ligating is performed using a kinase, wherein the kinase is a polynucleotide kinase, and a DNA ligase.

8. The method of claim 1 , wherein the RNA is an mRNA.

9. The method of claim 1 , wherein the capture domain is positioned 3′ relative to the spatial barcode in the capture probe.

10. The method of claim 1 , wherein the capture domain comprises a poly(T) sequence.

11. The method of claim 1 , wherein the capture probe further comprises a unique molecular identifier and/or a cleavage domain.

12. The method of claim 3 , wherein the capture probe further comprises a cleavage domain and the method further comprises, between the ligating step and the determining step, a step of releasing the blunt-ended double-stranded DNA product from the array via cleavage of the cleavage domain.

13. The method of claim 1 , wherein the determining in step (D comprises sequencing (i) all or a part of the sequence of the RNA or a complement thereof, or (ii) the sequence of the spatial barcode or a complement thereof.

14. The method of claim 13 , wherein the sequencing is high throughput sequencing.

15. The method of claim 13 , wherein the sequencing is sequencing by ligation or hybridization of labelled probes.

16. The method of claim 1 , wherein the method further comprises, between the ligating step and the determining step, creating a library for sequencing from the double-stranded DNA product, wherein the step of creating the library comprises amplification, wherein the amplification comprises polymerase chain reaction and the method further comprises sequencing the library.

17. The method of claim 1 , wherein the releasing in step (b), comprises permeabilizing the biological sample.

18. The method of claim 1 , wherein the array is on a slide or flowcell, and wherein the slide or flowcell comprises beads and/or wells.

19. The method of claim 1 , wherein the biological sample is a tissue sample.

20. The method of claim 19 , wherein the tissue sample is a tissue section.

21. The method of claim 20 , wherein the tissue section is a fixed tissue section.

22. The method of claim 20 , wherein the tissue section is a fresh, frozen tissue section.

23. The method of claim 1 , wherein the method further comprises one or both of staining and imaging the biological sample.

24. A kit comprising:

an array comprising a plurality of capture probes, wherein a capture probe of the plurality comprises (i) a spatial barcode and (ii) a capture domain that binds to an RNA;

DNA polymerase I;

DNA ligase; and

a double-stranded sequencing adaptor.

25. The kit of claim 24 , wherein the capture domain is positioned 3′ of the spatial barcode in the capture domain.

26. The kit of claim 24 , wherein the capture probe further comprises a unique molecular identifier and/or a cleavage domain.

27. The kit of claim 24 , wherein the array is on a slide or flowcell.

28. The kit of claim 27 , wherein the slide or flowcell comprises beads or wells.

29. The kit of claim 24 , wherein the kit further comprises one or more of Taq polymerase, a polynucleotide kinase (PNK), a reverse transcriptase, a Klenow fragment, and T4 DNA polymerase.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 10, 2023
From: STOECKIUS, MARLON
To: SPATIAL TRANSCRIPTOMICS AB
Reel/Frame 065527/0927 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 10, 2023
From: SPATIAL TRANSCRIPTOMICS AB
To: 10X GENOMICS, INC.
Reel/Frame 065528/0037 →
Continuity (3)
Continuation 17368276 · Jul 6, 2021
Provisional Application 63048627 · Jul 6, 2020
Related Publication 20230383344A1 · Nov 30, 2023
Cited By (44)
US 12,195,790 US 12,203,134 US 12,209,280 US 12,223,751 US 12,228,544 US 12,234,505 US 12,241,060 US 12,241,890 US 12,249,085 US 12,265,079 US 12,270,077 US 12,275,988 US 12,281,357 US 12,286,673 US 12,287,264 US 12,297,486 US 12,297,487 US 12,297,488 US 12,344,892 US 12,365,935 US 12,365,942 US 12,371,688 US 12,378,607 US 12,385,083 US 12,391,979 US 12,391,980 US 12,399,123 US 12,405,264 US 12,416,603 US 12,435,363 US 12,442,045 US 12,497,654 US 12,508,590 US 12,545,949 US 12,553,805 US 12,553,898 US 12,566,113 US 12,566,114 US 12,571,029 US 12,624,475 US 12,637,706 US 12,692,492 US 12,735,743 US 12,742,199